{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:41:37Z","timestamp":1789468897511,"version":"build-2803163510"},"reference-count":158,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.rmr.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T09:49:48Z","timestamp":1665395388000},"page":"758-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Manifestations pulmonaires des maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme"],"prefix":"10.1016","volume":"39","author":[{"given":"W.","family":"Mauhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Subran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zeggane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Besset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Montardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2022.09.002_bib0795","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2017.11.002","article-title":"Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management","volume":"65","author":"Saudubray","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.rmr.2022.09.002_bib0800","doi-asserted-by":"crossref","first-page":"021102","DOI":"10.7189\/jogh.08.021102","article-title":"Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence","volume":"8","author":"Waters","year":"2018","journal-title":"J Glob Health"},{"key":"10.1016\/j.rmr.2022.09.002_bib0805","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.rmr.2022.09.002_bib0810","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2015.05.051","article-title":"A conserved circular network of coregulated lipids modulates innate immune responses","volume":"162","author":"K\u00f6berlin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.rmr.2022.09.002_bib0815","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4161\/auto.19469","article-title":"Autophagy in lysosomal storage disorders","volume":"8","author":"Lieberman","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.rmr.2022.09.002_bib0820","doi-asserted-by":"crossref","first-page":"e0136442","DOI":"10.1371\/journal.pone.0136442","article-title":"Epithelial-mesenchymal transition in kidney tubular epithelial cells induced by globotriaosylsphingosine and globotriaosylceramide","volume":"10","author":"Jeon","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2022.09.002_bib0825","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2019.10.010","article-title":"Pathogenesis of Fabry nephropathy: the pathways leading to fibrosis","volume":"129","author":"Rozenfeld","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib0830","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib0835","first-page":"31","article-title":"Cardiovascular histopathology of a 11-year old with mucopolysaccharidosis VII demonstrates fibrosis, macrophage infiltration, and arterial luminal stenosis","volume":"39","author":"Lew","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rmr.2022.09.002_bib0840","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.rmr.2022.09.002_bib0845","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2559.2006.02355.x","article-title":"Pulmonary involvement by Niemann-Pick disease. A report of six cases","volume":"48","author":"Nicholson","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.rmr.2022.09.002_bib0850","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/jcm11040920","article-title":"Acid sphingomyelinase deficiency: sharing experience of disease monitoring and severity in France","volume":"11","author":"Mauhin","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0855","article-title":"Fabry disease: current & novel therapeutic strategies. A narrative review","author":"Palaiodimou","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.rmr.2022.09.002_bib0860","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.revmed.2018.11.012","article-title":"[Gaucher disease: a review]","volume":"40","author":"Nguyen","year":"2019","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.rmr.2022.09.002_bib0865","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib0870","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","article-title":"Niemann-Pick diseases","volume":"113","author":"Vanier","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.rmr.2022.09.002_bib0875","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0880","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2022.09.002_bib0885","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","article-title":"Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials","volume":"66","author":"McGovern","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib0890","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beem.2014.08.004","article-title":"Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening","volume":"29","author":"Kingma","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib0895","first-page":"13","article-title":"Respiratory impairment in Niemann-Pick B disease: two case reports and review for the pulmonologist","volume":"76","author":"Capron","year":"2019","journal-title":"Respir Med Res"},{"key":"10.1016\/j.rmr.2022.09.002_bib0900","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ppul.20725","article-title":"Lung disease in Niemann-Pick disease","volume":"42","author":"Guillemot","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2022.09.002_bib0905","doi-asserted-by":"crossref","first-page":"200363","DOI":"10.1183\/16000617.0363-2020","article-title":"Interstitial lung disease in lysosomal storage disorders","volume":"30","author":"Borie","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.09.002_bib0910","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0761-8425(08)74353-5","article-title":"Niemann-Pick disease type B identified following an episode of bronchopneumonia","volume":"25","author":"Herv\u00e9","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.09.002_bib0915","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.09.002_bib0920","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/s1806-37562017000000062","article-title":"Niemann-Pick disease type B: HRCT assessment of pulmonary involvement","volume":"43","author":"Freitas","year":"2017","journal-title":"J Bras Pneumol Publicacao"},{"key":"10.1016\/j.rmr.2022.09.002_bib0925","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3390\/jcm10215029","article-title":"Prevalence of cancer in acid sphingomyelinase deficiency","volume":"10","author":"Mauhin","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0930","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0935","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib0940","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","article-title":"A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results","volume":"24 (7)","author":"Wasserstein","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0945","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0950","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","article-title":"One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency","volume":"23","author":"Diaz","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0955","doi-asserted-by":"crossref","first-page":"E441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rmr.2022.09.002_bib0960","doi-asserted-by":"crossref","first-page":"E7159","DOI":"10.3390\/ijms21197159","article-title":"Value of glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review","volume":"21","author":"Revel-Vilk","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rmr.2022.09.002_bib0965","first-page":"72","article-title":"Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history","volume":"12 Suppl. 1","author":"Baris","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.rmr.2022.09.002_bib0970","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/B978-0-444-59565-2.00040-X","article-title":"Gaucher disease","volume":"113","author":"Mignot","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.rmr.2022.09.002_bib0975","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2012-07-442467","article-title":"Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease","volume":"121","author":"Franco","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rmr.2022.09.002_bib0980","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher disease in bone: from pathophysiology to practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.rmr.2022.09.002_bib0985","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib0990","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.3390\/cells8040364","article-title":"GBA, Gaucher disease, and Parkinson's disease: from genetic to clinic to new therapeutic approaches","volume":"8","author":"Riboldi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.rmr.2022.09.002_bib0995","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1000","series-title":"Protocole National de Diagnostic et de Soins (PNDS) Maladie de Gaucher [Internet]","author":"Camou","year":"2022"},{"key":"10.1016\/j.rmr.2022.09.002_bib1005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/94.8.407","article-title":"Lung involvement and enzyme replacement therapy in Gaucher's disease","volume":"94","author":"Goitein","year":"2001","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.rmr.2022.09.002_bib1010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1034\/j.1399-0004.2003.00060.x","article-title":"Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease","volume":"63","author":"Miller","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm.157.3.9706057","article-title":"Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?","volume":"157","author":"Santamaria","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1030","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2559.2012.04261.x","article-title":"Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease","volume":"61","author":"den Bakker","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1040","first-page":"002802","article-title":"Pulmonary involvement responsive to enzyme replacement therapy in an elderly patient with Gaucher disease","volume":"8","author":"Vellas","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.revmed.2020.08.019","article-title":"[Fabry disease: a review]","volume":"42","author":"Michaud","year":"2021","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.rmr.2022.09.002_bib1050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ijc.2910480610","article-title":"Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors","volume":"48","author":"Oosterwijk","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rmr.2022.09.002_bib1055","doi-asserted-by":"crossref","first-page":"e0233460","DOI":"10.1371\/journal.pone.0233460","article-title":"Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease","volume":"15","author":"Mauhin","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2022.09.002_bib1060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cge.14102","article-title":"Challenging the traditional approach for interpreting genetic variants: lessons from Fabry disease","volume":"101","author":"Germain","year":"2022","journal-title":"Clin Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmedgenet-2019-106467","article-title":"Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup","volume":"57","author":"Germain","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1080","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00405-021-07173-x","article-title":"Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY","volume":"279","author":"Asquier-Khati","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41436-020-00968-z","article-title":"Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease","volume":"23","author":"Bichet","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1090","series-title":"Protocole National de Diagnostic et de Soins (PNDS) Maladie de Fabry","author":"Germain","year":"2021"},{"key":"10.1016\/j.rmr.2022.09.002_bib1095","first-page":"83","article-title":"Uncertain diagnosis of Fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up","volume":"17","author":"van der Tol","year":"2014","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rmr.2022.09.002_bib1100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1105","series-title":"Fabry disease: perspectives from 5 years of FOS [Internet]","article-title":"Pulmonary involvement in Fabry disease","author":"Aubert","year":"2006"},{"key":"10.1016\/j.rmr.2022.09.002_bib1110","doi-asserted-by":"crossref","first-page":"e000277","DOI":"10.1136\/bmjresp-2018-000277","article-title":"Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy","volume":"5","author":"Franzen","year":"2018","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.rmr.2022.09.002_bib1115","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1183\/09031936.00004110","article-title":"Prevalence of airflow obstruction in smokers and never-smokers in Switzerland","volume":"36","author":"Bridevaux","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10545-007-0616-9","article-title":"Natural history of the respiratory involvement in Anderson-Fabry disease","volume":"30","author":"Magage","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1125","doi-asserted-by":"crossref","first-page":"e0180437","DOI":"10.1371\/journal.pone.0180437","article-title":"Long-term follow-up of pulmonary function in Fabry disease: a bi-center observational study","volume":"12","author":"Franzen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2022.09.002_bib1130","doi-asserted-by":"crossref","first-page":"26721","DOI":"10.3402\/ecrj.v2.26721","article-title":"Fabry disease, respiratory symptoms, and airway limitation\u00a0\u2013\u00a0a systematic review","volume":"2","author":"Svensson","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2143\/AC.65.2.2047052","article-title":"Cardiopulmonary involvement in Fabry's disease","volume":"65","author":"Koskenvuo","year":"2010","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ehjcvp\/pvab025","article-title":"Treatment of Fabry disease management with migalastat\u2014outcome from a prospective 24 months observational multicenter study (FAMOUS)","volume":"8","author":"Lenders","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.rmr.2022.09.002_bib1145","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41436-019-0451-z","article-title":"Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study","volume":"21","author":"Germain","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1150","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.3390\/biom10091339","article-title":"Pompe disease: new developments in an old lysosomal storage disorder","volume":"10","author":"Meena","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.rmr.2022.09.002_bib1155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0041-1735250","article-title":"Clinical and genetic aspects of juvenile onset Pompe disease","volume":"53","author":"Holzwarth","year":"2022","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.rmr.2022.09.002_bib1160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":"G\u00fcng\u00f6r","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1165","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.3390\/jcm10214828","article-title":"A systematic review and meta-analysis of enzyme replacement therapy in late-onset Pompe disease","volume":"10","author":"Dornelles","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nmd.2020.10.009","article-title":"Cardiovascular disease in non-classic Pompe disease: a systematic review","volume":"31","author":"van Kooten","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.rmr.2022.09.002_bib1175","first-page":"S4","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/0004-282X20130022","article-title":"Muscle biopsy in Pompe disease","volume":"71","author":"Werneck","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.rmr.2022.09.002_bib1185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1469-8749.2003.tb00966.x","article-title":"Pompe disease and physical disability","volume":"45","author":"Haley","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1195","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1200","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1205","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.21037\/jtd-cus-2020-007","article-title":"Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review","volume":"12","author":"Shah","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1210","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1215","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/atm.2019.04.70","article-title":"Long-term outcome and unmet needs in infantile-onset Pompe disease","volume":"7","author":"Hahn","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/dmcn.13740","article-title":"Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain","volume":"60","author":"Ebbink","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1230","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","volume":"269","author":"Sarah","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1240","doi-asserted-by":"crossref","first-page":"e1756","DOI":"10.1212\/WNL.0000000000008441","article-title":"Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease","volume":"93","author":"Harlaar","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2022.01.001","article-title":"Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease","volume":"32","author":"Winkler","year":"2022","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.rmr.2022.09.002_bib1250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/nan.12580","article-title":"An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease","volume":"46","author":"Kulessa","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.21037\/atm.2019.04.15","article-title":"Challenges in treating Pompe disease: an industry perspective","volume":"7","author":"Do","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1265","first-page":"536","article-title":"Long-term safety and efficacy of avalglucosidase alfa in patients with late-onset Pompe disease","volume":"99(5)","author":"Dimachkie","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2022.09.002_bib1270","doi-asserted-by":"crossref","first-page":"863667","DOI":"10.3389\/fphar.2022.863667","article-title":"The inflammation in the cytopathology of patients with mucopolysaccharidoses\u00a0\u2013\u00a0immunomodulatory drugs as an approach to therapy","volume":"13","author":"Wiesinger","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1275","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.revmed.2019.11.010","article-title":"Mucopolysaccharidosis: a review","volume":"41","author":"Michaud","year":"2020","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.rmr.2022.09.002_bib1280","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.RA119.009879","article-title":"Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate","volume":"294","author":"Sepuru","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmr.2022.09.002_bib1285","doi-asserted-by":"crossref","first-page":"C1271","DOI":"10.1152\/ajpcell.00095.2022","article-title":"The glycosaminoglycan interactome 2.0","volume":"322","author":"Vallet","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1290","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.3390\/ijms20020327","article-title":"Molecular pathways and respiratory involvement in lysosomal storage diseases","volume":"20","author":"Faverio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rmr.2022.09.002_bib1295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1300","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/crj.13150","article-title":"Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: a state-of-the art review","volume":"14","author":"Jezela-Stanek","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1305","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10545-016-9973-6","article-title":"Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome","volume":"39","author":"Hendriksz","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1310","first-page":"E63","article-title":"Respiratory dysfunction in children and adolescents with mucopolysaccharidosis types I, II, IVA, and VI","volume":"10","author":"Tulebayeva","year":"2020","journal-title":"Diagn Basel Switz"},{"key":"10.1016\/j.rmr.2022.09.002_bib1315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1320","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.rmr.2022.09.002_bib1325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.22774","article-title":"Characterization of pulmonary function impairments in patients with mucopolysaccharidoses\u00a0\u2013\u00a0changes with age and treatment","volume":"49","author":"Lin","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1330","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijporl.2005.01.017","article-title":"Otorhinolaryngological manifestations of the mucopolysaccharidoses","volume":"69","author":"Simmons","year":"2005","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-016-0425-z","article-title":"Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis","volume":"11","author":"Rutten","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1340","first-page":"33","article-title":"Management of life-threatening tracheal stenosis and tracheomalacia in patients with mucopolysaccharidoses","volume":"33","author":"Kampmann","year":"2017","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rmr.2022.09.002_bib1345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2020.07.004","article-title":"The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I","volume":"132","author":"Broomfield","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ymgme.2018.04.013","article-title":"Efficacy of Idursulfase therapy in patients with Mucopolysaccharidosis type II who initiated enzyme replacement therapy in adult age. A systematic review of the literature","volume":"124","author":"P\u00e9rez-L\u00f3pez","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13023-021-02074-y","article-title":"Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience","volume":"16","author":"Quijada-Fraile","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1360","first-page":"CD009806","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI","volume":"9","author":"Brunelli","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2022.09.002_bib1365","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ymgme.2019.06.008","article-title":"Enzyme replacement therapy initiated in adulthood: findings from the mucopolysaccharidosis VI Clinical Surveillance Program","volume":"127","author":"Lampe","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1370","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/00034894211032778","article-title":"Airway management of the deformed trachea using T-Tube stents in patients with mucopolysaccharidosis type IVA","volume":"131","author":"Lee","year":"2022","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijporl.2016.02.015","article-title":"Tracheobronchial stents in mucopolysaccharidosis","volume":"83","author":"Karl","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1380","doi-asserted-by":"crossref","first-page":"644671","DOI":"10.3389\/fphar.2021.644671","article-title":"Hermansky-Pudlak syndrome and lung disease: pathogenesis and therapeutics","volume":"12","author":"Vel\u00e1zquez-D\u00edaz","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1385","doi-asserted-by":"crossref","first-page":"200193","DOI":"10.1183\/16000617.0193-2020","article-title":"Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease","volume":"30","author":"Yokoyama","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.09.002_bib1390","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0040-1708088","article-title":"Hermansky-Pudlak syndrome","volume":"41","author":"De Jesus Rojas","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1395","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/pcmr.12534","article-title":"NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients","volume":"29","author":"Wei","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.rmr.2022.09.002_bib1400","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/humu.23968","article-title":"Hermansky-Pudlak syndrome: mutation update","volume":"41","author":"Huizing","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rmr.2022.09.002_bib1405","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2214\/ajr.179.4.1790887","article-title":"Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies","volume":"179","author":"Avila","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1827.2005.01811.x","article-title":"Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syndrome): severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation","volume":"55","author":"Tang","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.rmr.2022.09.002_bib1415","doi-asserted-by":"crossref","DOI":"10.3402\/ecrj.v2.26385","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis\u00a0\u2013\u00a0preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine","volume":"2","author":"Myll\u00e4rniemi","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.rmr.2022.09.002_bib1420","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","article-title":"Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome","volume":"76","author":"Gahl","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1425","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ymgme.2018.07.012","article-title":"Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"125","author":"O\u2019Brien","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1430","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1435","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.healun.2004.11.015","article-title":"Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome","volume":"24","author":"Lederer","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2022.09.002_bib1440","doi-asserted-by":"crossref","first-page":"e0194193","DOI":"10.1371\/journal.pone.0194193","article-title":"Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation","volume":"13","author":"El-Chemaly","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2022.09.002_bib1445","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1450","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2019.12.007","article-title":"Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies","volume":"173","author":"Bublil","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.rmr.2022.09.002_bib1455","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/s41436-018-0419-4","article-title":"Revising the psychiatric phenotype of homocystinuria","volume":"21","author":"Almuqbil","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13816810.2020.1821384","article-title":"Ocular manifestations in classic homocystinuria","volume":"42","author":"Gus","year":"2021","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1465","first-page":"100693","article-title":"Cardiovascular findings in classic homocystinuria","volume":"25","author":"Kalil","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.rmr.2022.09.002_bib1470","doi-asserted-by":"crossref","first-page":"e1214","DOI":"10.1002\/mgg3.1214","article-title":"Classical homocystinuria: a common inborn error of metabolism? An epidemiological study based on genetic databases","volume":"8","author":"Weber Hoss","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2009.09.009","article-title":"A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"99","author":"Skovby","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13023-016-0550-8","article-title":"Update on lysinuric protein intolerance, a multi-faceted disease retrospective cohort analysis from birth to adulthood","volume":"12","author":"Mauhin","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1485","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s10038-019-0620-6","article-title":"Overview of symptoms and treatment for lysinuric protein intolerance","volume":"64","author":"Noguchi","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.rmr.2022.09.002_bib1490","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2012.02.010","article-title":"Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a classic urea cycle disorder","volume":"106","author":"Ogier de Baulny","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rmr.2022.09.002_bib1495","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.molimm.2015.07.006","article-title":"Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport","volume":"67","author":"Kurko","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1500","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2006-0262OC","article-title":"Alveolar macrophages from normal subjects lack the NOS-related system y+ for arginine transport","volume":"37","author":"Rotoli","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1505","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpeds.2007.01.043","article-title":"Nephropathy advancing to end-stage renal disease: a novel complication of lysinuric protein intolerance","volume":"150","author":"Tanner","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2022.09.002_bib1510","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1378\/chest.104.4.1176","article-title":"Pulmonary manifestations in lysinuric protein intolerance","volume":"104","author":"Parto","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.09.002_bib1515","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpeds.2004.04.047","article-title":"Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance","volume":"145","author":"Santamaria","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2022.09.002_bib1520","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/ajrccm.153.2.8564125","article-title":"Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods","volume":"153","author":"Santamaria","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1525","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10545-014-9777-5","article-title":"Lung involvement in children with lysinuric protein intolerance","volume":"38","author":"Valimahamed-Mitha","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1530","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4187\/respcare.01125","article-title":"Pulmonary alveolar proteinosis","volume":"56","author":"Khan","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.rmr.2022.09.002_bib1535","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1084\/jem.20080759","article-title":"Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1","volume":"205","author":"Martinez-Moczygemba","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-3476(95)70552-X","article-title":"Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course","volume":"126","author":"Parenti","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2022.09.002_bib1545","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-5-32","article-title":"In lysinuric protein intolerance system y\u00a0+\u00a0L activity is defective in monocytes and in GM-CSF-differentiated macrophages","volume":"5","author":"Barilli","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2022.09.002_bib1550","doi-asserted-by":"crossref","first-page":"723003","DOI":"10.3389\/fmolb.2021.723003","article-title":"PROLIDASE: a review from discovery to its role in health and disease","volume":"8","author":"Eni-Aganga","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.rmr.2022.09.002_bib1555","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13223-022-00658-2","article-title":"Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins","volume":"18","author":"Alrumayyan","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.rmr.2022.09.002_bib1560","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41436-021-01200-2","article-title":"Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases","volume":"23","author":"Rossignol","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.rmr.2022.09.002_bib1565","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/MPG.0000000000002402","article-title":"A novel manifestation of prolidase deficiency in a toddler diagnosed with very-early-onset Crohn disease","volume":"69","author":"Rizvi","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.rmr.2022.09.002_bib1570","article-title":"Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult","volume":"55","author":"Cottin","year":"2020","journal-title":"Eur Respir J [Internet]"},{"key":"10.1016\/j.rmr.2022.09.002_bib1575","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.3390\/biology9050108","article-title":"Clinical genetics of prolidase deficiency: an updated review","volume":"9","author":"Spodenkiewicz","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.rmr.2022.09.002_bib0790","doi-asserted-by":"crossref","first-page":"190053","DOI":"10.1183\/16000617.0053-2019","article-title":"The genetics of interstitial lung diseases","volume":"28","author":"Borie","year":"2019","journal-title":"Eur Respir Rev"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522003047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522003047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:24:34Z","timestamp":1760106274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842522003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":158,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0761842522003047"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2022.09.002","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations pulmonaires des maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}